Predicted protein targets (top 15)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LMNA | P02545 | 2/20 | 0.48 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.42 |
| ▸ | RAB9A | P51151 | 2/20 | 0.42 |
| ▸ | NPC1 | O15118 | 1/20 | 0.42 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.42 |
| ▸ | CFD | P00746 | 2/20 | 0.41 |
| ▸ | ELANE | P08246 | 1/20 | 0.41 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.41 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.40 |
| ▸ | ACHE | P22303 | 1/20 | 0.39 |
| ▸ | MAOB | P27338 | 2/20 | 0.39 |
| ▸ | TSHR | P16473 | 2/20 | 0.39 |
| ▸ | GAA | P10253 | 1/20 | 0.39 |
| ▸ | CYP4F2 | P78329 | 1/20 | 0.38 |
| ▸ | CYP4A11 | Q02928 | 1/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL9222607 | 0.84 | LMNA (0.50) | LMNAALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL7847835 | 0.83 | LMNA (0.48) | LMNAALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL8216520 | 0.83 | CFD (0.49) | LMNAALDH1A1RAB9ACFDKDM4E | |
| SCHEMBL6650657 | 0.81 | CYP4F2 (0.44) | ALDH1A1RAB9ASMN1; SMN2CFDKDM4E | |
| SCHEMBL9314196 | 0.80 | LMNA (0.46) | LMNAALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL3639665 | 0.80 | BACE1 (0.51) | LMNAALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL8897775 | 0.79 | CFD (0.39) | LMNAALDH1A1RAB9ACFDKDM4E | |
| SCHEMBL9643353 | 0.79 | HSD17B2 (0.51) | LMNAALDH1A1RAB9ANPC1SMN1; SMN2 | |
| SCHEMBL1017686 | 0.78 | RAB9A (0.52) | ALDH1A1RAB9ANPC1SMN1; SMN2KDM4E | |
| SCHEMBL27001734 | 0.78 | GSK3B (0.39) | ALDH1A1RAB9ACFDKDM4ETSHR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250229198-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I (CZ) | 2025-07-17 | — | — | US | disclosed |
| US-12268977-B2 | Compounds for separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR. V.V.I. (CZ) | 2025-04-08 | — | — | US | disclosed |
| EP-3717466-B1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR V V I (CZ) | 2022-01-05 | — | — | EP | disclosed |
| EP-3717466-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | Ustav Organicke Chemie a Biochemie AV CR, v.v.i. (CZ) | 2020-10-07 | — | — | EP | disclosed |
| US-20200282331-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2020-09-10 | — | — | US | disclosed |
| US-20200282331-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | USTAV ORGANICKE CHEMIE A BIOCHEMIE AV CR, V.V.I. (CZ) | 2020-09-10 | — | — | US | disclosed |
| EP-3492460-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS, METHOD OF SEPARATION, AND USE THEREOF | Ustav Organicke Chemie A Biochemie Av Cr, V.v.i. (CZ) | 2019-06-05 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20250229198-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | SCO2, SOD3, SLC39A3 | LMNA 593/4885ALDH1A1 4085/4885RAB9A 1520/4885 |
| US-20200282331-A1 | COMPOUNDS FOR SEPARATION OF RARE EARTH ELEMENTS AND S-, P-, D- METALS, METHOD OF SEPARATION, AND USE THEREOF | SCLY, SFXN1, PTCD3 | LMNA 2040/4885ALDH1A1 2634/4885RAB9A 1629/4885 |
| US-12268977-B2 | Compounds for separation of rare earth elements and s-, p-, d-metals, method of separation, and use thereof | SCLY, SFXN1, PTCD3 | LMNA 2040/4885ALDH1A1 2634/4885RAB9A 1629/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.